A distinctive subset of PEComas harbors TFE3 gene fusions

American Journal of Surgical Pathology

Volumn 34, Issue 10, 2010, Pages 1395-1406

  Argani, Pedram ^a   Aulmann, Sebastian ^b   Illei, Peter B ^a   Netto, George J ^a   Ro, Jae ^c   Cho, Hyun Yee ^d   Dogan, Snjezana ^e   Ladanyi, Marc ^e   Martignoni, Guido ^f   Goldblum, John R ^g   Weiss, Sharon W ^h  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Asan Medical Center   (South Korea)

^d Gachon University College of Medicine   (South Korea)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF VERONA   (Italy)

^g LERNER RESEARCH INSTITUTE   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chromosome translocation; PEComa; TFE3

Indexed keywords

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CATHEPSIN K; CTSK PROTEIN, HUMAN; MESSENGER RNA; TFE3 PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIVASCULAR EPITHELIOID CELL TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CATHEPSIN K; CHILD; FEMALE; GENE FUSION; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PERIVASCULAR EPITHELIOID CELL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 77957935854     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181f17ac0     Document Type: Article

References (32)

1. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas. Morphologic, Immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002;26:1553-1566.
2. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159: 179-192.
3. Argani P, Aulmann S, Karanjawala Z, et al. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PE Coma, carcinoma, and melanoma. Am J Surg Pathol. 2009;33:409-419.
4. Argani P, Hicks J, De Marzo A, et al. Xp11 translocation renal cell carcinoma (RCC): extended Immunohistochemical (IHC) profile emphasizing novel RCC markers. Am J Surg Pathol. 2010;34: 1295-1303.
5. Argani P, Ladanyi M. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble JN, Sauter G, Epstein J, et al, eds. Pathology and Genetics of Tumors of the Urinary System & Male Genital Organs. Lyon, France: IARC; 2004:37-38.
6. Argani P, Lae M, Ballard ET, et al. Translocation carcinomas of kidney after chemotherapy in childhood. J Clin Oncol. 2006;24: 1529-1524.
7. Argani P, Lae M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12). Clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA-PCR. Am J Surg Pathol. 2005;29:230-240.
8. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immuno-reactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific Immunohistochemical assay. Am J Surg Pathol. 2003; 27:750-761.
9. Armah HB, Parwani AV. Perivascular epithelioid cell tumor. Arch Pathol Lab Med. 2009;133:648-654.
10. Aulmann S, Longerich T, Schirmacher P, et al. Detection of the ASPCR-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas. Histopathology. 2007;50:881-886.
11. Chang I-W, Huang H-Y, Sung M-T. Melanotic Xp11 translocation renal cancer. A case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts. Am J Surg Pathol. 2009;33:1894-1901.
12. Cho HY, Chung DH, Khurana H, et al. The role of TFE3 in PE Coma. Histopathology. 2008;53:236-238.
13. Clark J, Lu YJ, Sidhar SK, et al. Fusion of the splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene. 1997;15:2233-2239.
14. Dickson BC, Brooks JS, Pasha TL, et al. Evaluation of TFE3 expression in tumors of microphthalmia-associated transcription factor (MiTF) family and its potential diagnostic significance. Mod Pathol. 2009;22(S1):13A. (abstract #45).
15. Eble JN. Angiomyolipoma of kidney. Semin Diagn Pathol. 1998;15: 21-40.
16. Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathology. 2010;41:1-15.
17. Folpe AL, Mentzel T, Lehr H-A, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin. Am J Surg Pathol. 2005;29:1558-1575.
18. Francis F, Nonaka D. A study of MiTF/TFE transcription factors and melanocytic differentiation markers in angiomyolipoma. Mod Pathol. 2009;22(S1):13A-14A. (abstract #47).
19. Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436:117-122.
20. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumors: where are we now? J Clin Pathol. 2008;61:428-437.
21. Henske EP, Scheithauer BW, Short MP, et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet. 1996;59:400-406.
22. Hornick JL, Fletcher CD. PE Coma: what do we know so far? Histopathology. 2006;48:75-82.
23. Kennerson H, Folpe AL, Tayayama TK, et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol. 2007;38: 1361-1371.
24. Kuroda N, Goda M, Kazakov DV, et al. Perivascular epithelioid cell tumor of the nasal cavity with TFE3 expression. Pathology International. 2009;59:769-770.
25. Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17) (p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48-57.
26. Martignoni G, Bonetti F, Chilosi M, et al. Cathepsin-K expression in both classic and epithelioid angiomyolipoma of the kidney. Mod Pathol. 2009;22(S1):181A.
27. Martignoni G, Pea M, Gobbo S, et al. Cathepsin-K immunor-eactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol. 2009;22: 1016-1022.
28. Martignoni G, Pea M, Reghellin D, et al. PE Comas: the past, the present and the future. Virchows Arch. 2008;452:119-132.
29. Pan CC, Chung M-Y, Ng K-F, et al. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumor (PE Coma): genetic evidence for the relationship of PE Comas with angiomyolipoma. J Pathol. 2008;214:387-393.
30. Righi A, Dimosthenous K, Rosai J. PE Coma: another member of the MiT tumor family? Int J Surg Pathol. 2008;16:16-20.
31. Tanaka M, Kato K, Gomi K, et al. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma. Am J Surg Pathol. 2009;33:1416-1420.
32. Weiss SW. Alveolar soft part sarcoma: are we at the end or just the beginning of our quest? Am J Pathol. 2002;160:1197-1199.